Primary Sjögren's syndrome and risk of ischemic stroke: A nationwide study

Clinical Rheumatology

Volumn 33, Issue 7, 2014, Pages 931-937

  Chiang, Chia Hung ^a,b,c   Liu, Chia Jen ^b,c   Chen, Ping Jen ^c,d   Huang, Chin Chou ^b,c   Hsu, Chien Yi ^b,c   Chan, Wan Leong ^b,c   Huang, Po Hsun ^b,c   Chen, Tzeng Ji ^b,c   Lin, Shing Jong ^b,c   Chen, Jaw Wen ^b,c   Leu, Hsin Bang ^b,c  

^a Da Chien General Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Atherosclerosis; Ischemic stroke; Primary Sj gren's syndrome

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; STEROID;

ADULT; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SJOEGREN SYNDROME; AGED; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COMPLICATION; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; TAIWAN; TREATMENT OUTCOME;

ADULT; AGED; ATHEROSCLEROSIS; BRAIN ISCHEMIA; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SJOGREN'S SYNDROME; STROKE; TAIWAN; TREATMENT OUTCOME;

EID: 84903546886     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2573-7     Document Type: Article

References (34)

1. Sherer Y, Zinger H, Shoenfeld Y (2010) Atherosclerosis in systemic lupus erythematosus. Autoimmunity 43:98-102
2. Fox RI (2005) Sjogren's syndrome. Lancet 366:321-331
3. Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum 58:15-25
4. Zhang NZ, Shi CS, Yao QP et al (1995) Prevalence of primary Sjogren's syndrome in China. J Rheumatol 22:659-661
5. Nordmark G, Alm GV, Ronnblom L (2006) Mechanisms of disease: primary Sjogren's syndrome and the type I interferon system. Nat Clin Pract Rheumatol 2:262-269
6. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554-558 (Pubitemid 34539104)
7. Andonopoulos AP, Lagos G, Drosos AA et al (1990) The spectrumof neurological involvement in Sjogren's syndrome. Br J Rheumatol 29: 21-23 (Pubitemid 20040234)
8. Morgen K, McFarland HF, Pillemer SR (2004) Central nervous system disease in primary Sjogren's syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 34:623-630 (Pubitemid 39643125)
9. Chai J, Logigian EL (2010) Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol 23:509-513
10. Martinez S, Caceres C, Mataro M et al (2010) Is there progressive cognitive dysfunction in sjogren syndrome? A preliminary study. Acta Neurol Scand 122:182-188
11. Gokcay F, Oder G, Celebisoy N et al (2008) Headache in primary sjogren's syndrome: a prevalence study. Acta Neurol Scand 118:189-192
12. Lodde BM, Sankar V, Kok MR et al (2006) Serum lipid levels in Sjogren's syndrome. Rheumatology (Oxford) 45:481-484
13. Vaudo G, Bocci EB, Shoenfeld Y et al (2005) Precocious intima-media thickening in patients with primary Sjogren's syndrome. Arthritis Rheum 52:3890-3897 (Pubitemid 41798228)
14. Weng MY, Huang YT, Liu MF et al (2012) Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan. Ann Rheum Dis 71:524-527
15. Chiang CH, Huang CC, Chan WL et al (2011) Association between mycoplasma pneumonia and increased risk of ischemic stroke: a nationwide study. Stroke J Cereb Circ 42:2940-2943
16. Chen HJ, Bai CH, Yeh WT et al (2006) Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke J Cereb Circ 37:1060-1064
17. Shoenfeld Y, Gerli R, Doria A et al (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112:3337-3347 (Pubitemid 43739380)
18. de Leeuw FE, de Groot JC, Oudkerk M et al (1999) A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 46:827-833
19. Buyck JF, Dufouil C, Mazoyer B et al (2009) Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-city Dijon study. Stroke J Cerebral Circ 40: 2327-2331
20. Coates T, Slavotinek JP, Rischmueller M et al (1999) Cerebral white matter lesions in primary Sjogren's syndrome: a controlled study. J Rheumatol 26:1301-1305 (Pubitemid 29268082)
21. Escudero D, Latorre P, Codina M et al (1995) Central nervous system disease in Sjogren's syndrome. Ann Med Interne 146:239-242
22. Ramos-Casals M, Solans R, Rosas J et al (2008) Primary sjogren syndrome in spain: clinical and immunologic expression in 1010 patients. Medicine 87:210-219
23. Gono T, Kawaguchi Y, Katsumata Y et al (2011) Clinical manifestations of neurological involvement in primary Sjogren's syndrome. Clin Rheumatol 30:485-490
24. Perez-De-Lis M, Akasbi M, Siso A et al (2010) Cardiovascular risk factors in primary Sjogren's syndrome: a case-control study in 624 patients. Lupus 19:941-948
25. Zoller B, Li X, Sundquist J et al (2012) Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from sweden. BMC Neurol 12:41
26. Chiu CC, Huang CC, Chan WL, Chung CM, Huang PH, Lin SJ, Chen JW, Leu HB (2012) Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study. Intern Med 51:17-21
27. Pasoto SG, Chakkour HP, Natalino RR et al (2012) Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjogren's syndrome. Clin Rheumatol 31(9):1331-8
28. Theander E, Manthorpe R, Jacobsson LT (2004) Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study. Arthritis Rheum 50:1262-1269 (Pubitemid 38480838)
29. Chen PL, Wang PY, Sheu WH et al (2006) Changes of brachial flow-mediated vasodilation in different ischemic stroke subtypes. Neurology 67:1056-1058 (Pubitemid 44454604)
30. Gerli R, Vaudo G, Bocci EB et al (2010) Functional impairment of the arterial wall in primary Sjogren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res 62:712-718
31. Rachapalli SM, Kiely PD, Bourke BE (2009) Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome. Clin Rheumatol 28:587-590
32. Banerjee A, Fowkes FG, Rothwell PM (2010) Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention. Stroke J Cereb Circ 41: 2102-2107
33. Ramos-Casals M, Tzioufas AG, Stone JH et al (2010) Treatment of primary Sjogren's syndrome: a systematic review. JAMA 304:452-460
34. Lin HC, Lin YJ, Liu TC et al (2007) Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey. J Urban Health Bull NYAcad Med 84:604-614